Ticker > Company >

Cresanto Global share price

Cresanto Global Ltd.

BSE: 531207 SECTOR: Pharmaceuticals & Drugs  8.44 K   8   0

3.65
0 0
BSE: 15 Sep 4:00 PM

Price Summary

Today's High

₹ 3.65

Today's Low

₹ 3.65

52 Week High

₹ 3.65

52 Week Low

₹ 2.75

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1.56 Cr.

Enterprise Value

1.56 Cr.

No. of Shares

0.43 Cr.

P/E

0

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  -6.35

CASH

0 Cr.

DEBT

0 Cr.

Promoter Holding

32.27 %

EPS (TTM)

₹  -0.67

Sales Growth

0%

ROE

0 %

ROCE

0%

Profit Growth

40.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 Year40.55%
3 Year-19.4%
5 Year-36.69%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year0%
3 Year0%
5 Year-39.97%

Debt/Equity

0

Price to Cash Flow

-25.7

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 32.27 0.00
Jun 2025 32.27 0.00
Mar 2025 32.27 0.00
Dec 2024 28.36 0.00
Sep 2024 28.36 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of -19.4040010741086% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of 0% over the past 3 years
  • Company has negative cash flow from operations of -0.060686.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 0 0 0 0 0.05
Total Expenditure 0.02 0.26 0.33 0.09 0.06
Operating Profit -0.02 -0.26 -0.33 -0.09 -0.01
Other Income 0 0.01 0.52 0 0
Interest 0 0 0.12 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.02 -0.25 0.07 -0.09 -0.01
Tax 0 0 0 0 0
Profit After Tax -0.02 -0.25 0.07 -0.09 -0.01
Adjusted EPS (Rs) -0.04 -0.58 0.16 -0.22 -0.02

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0 0 0
Total Expenditure 0.06 0.07 0.08 0.19 0.1
Operating Profit -0.06 -0.07 -0.08 -0.19 -0.1
Other Income 0.01 0.01 0 0.02 0
Interest 0 0 0 0 0
Depreciation 0.01 0.01 0.01 0.01 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.06 -0.07 -0.08 -0.17 -0.1
Tax 0 0 0 0 0
Net Profit -0.06 -0.07 -0.08 -0.17 -0.1
Adjusted EPS (Rs.) -0.13 -0.16 -0.19 -0.4 -0.24

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.27 4.27 4.27 4.27 4.27
Total Reserves -6.26 -6.33 -6.41 -6.58 -6.68
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 2.21 2.37 2.43
Current liabilities 2.24 2.3 0.17 0.09 0.13
Total Liabilities 0.26 0.25 0.25 0.16 0.15
Assets
Net Block 0.17 0.16 0.16 0.15 0.15
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 0.09 0.09 0.09 0.01 0.01
Total Assets 0.26 0.25 0.25 0.16 0.15
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.06 -0.07 -0.08 -0.17 -0.1
Adjustment 0.01 0.01 0.01 0.07 0.04
Changes in Assets & Liabilities 0.05 0.06 -2.13 -0.06 0
Tax Paid 0 0 0 0 0
Operating Cash Flow 0 0 -2.21 -0.16 -0.06
Investing Cash Flow 0 0 2.21 0.16 0.06
Financing Cash Flow 0 0 0 0 0
Net Cash Flow 0 0 0 0 0

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 28.36 28.36 32.27 32.27 32.27
hitesh bajoria - - 6.68 6.68 6.68
nishant n bajaj - - 9.05 9.05 9.05
prashant nathmal bajaj - - 7.09 7.09 7.09
tushar pandit awate - - 4.73 4.73 4.73
urmila hansraj sharma - - 4.73 4.73 4.73
ajai goyal 28.36 28.36 - - -
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 71.64 71.64 67.73 67.73 67.73
amzel limited 7.02 7.02 7.02 7.02 7.02
carnation corporate consu... - - 2.46 - 2.46
chandresh shantilal shah 1.14 1.14 1.14 1.14 1.14
first global stockbroking... 1.18 1.18 1.18 1.18 1.18
mandeep kapur 3.39 3.39 3.39 3.39 3.39
nord asia investment ltd 4.68 4.68 4.68 4.68 4.68
shailesh natvarlal gandhi... 3.66 3.66 3.66 3.66 3.66
carnation corporate consu... - 2.46 - 2.46 -
hitesh bajoria 1.96 1.96 - - -
nishant n bajaj 1.96 1.96 - - -
carnation corporate consu... 2.46 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Cresanto Global - Quaterly Results 6 Nov, 12:00 AM Raymed Labs informs about newspaper publication 24 May, 1:26 PM Cresanto Global - Quaterly Results 22 May, 5:50 PM Cresanto Global - Quaterly Results 22 May, 5:50 PM Raymed Labs informs about disclosure 27 Feb, 2:25 PM Raymed Labs informs about disclosure 27 Feb, 1:18 PM Raymed Labs informs about disclosure 27 Feb, 1:17 PM Raymed Labs informs about disclosure 19 Feb, 5:30 PM Raymed Labs informs about disclosure 19 Feb, 12:51 PM Raymed Labs informs about disclosure 19 Feb, 12:49 PM Raymed Labs informs about integrated filing 14 Feb, 2:58 PM Raymed Labs informs about post offer public announcement 6 Feb, 1:02 PM Raymed Labs - Quaterly Results 27 Jan, 8:04 PM Raymed Labs - Quaterly Results 27 Jan, 8:04 PM Raymed Labs informs about open offer 14 Jan, 5:04 PM Raymed Labs - Quaterly Results 6 Nov, 5:48 PM Raymed Labs - Quaterly Results 6 Nov, 5:48 PM Raymed Labs informs about newspaper advertisement 23 Aug, 11:11 AM Raymed Labs - Quaterly Results 12 Aug, 6:00 PM Raymed Labs - Quaterly Results 12 Aug, 6:00 PM Raymed Labs informs about newspaper advertisement 25 May, 2:21 PM Raymed Labs informs about newspaper advertisement 25 May, 12:38 PM Raymed Labs - Quaterly Results 24 May, 4:33 PM Raymed Labs - Quaterly Results 24 May, 4:33 PM Raymed Labs - Quaterly Results 24 May, 4:33 PM Raymed Labs informs about board meeting 13 May, 5:30 PM Raymed Labs - Quaterly Results 6 Feb, 12:41 PM Raymed Labs - Quaterly Results 6 Feb, 12:41 PM Raymed Labs - Quaterly Results 6 Feb, 12:41 PM Raymed Labs - Quaterly Results 4 Nov, 1:18 PM Raymed Labs - Quaterly Results 4 Nov, 1:18 PM Raymed Labs - Quaterly Results 4 Nov, 1:18 PM Raymed Labs informs about press release 8 Aug, 2:46 PM Raymed Labs - Quaterly Results 2 Aug, 4:37 PM Raymed Labs - Quaterly Results 2 Aug, 4:37 PM Raymed Labs - Quaterly Results 2 Aug, 4:37 PM Raymed Labs - Quaterly Results 7 Feb, 4:47 PM Raymed Labs - Quaterly Results 7 Feb, 4:47 PM Raymed Labs - Quaterly Results 7 Feb, 4:47 PM Raymed Labs - Quaterly Results 8 Aug, 5:55 PM Raymed Labs - Quaterly Results 8 Aug, 5:55 PM Raymed Labs informs about certificate 18 Apr, 3:07 PM Raymed Labs - Quaterly Results 11 Feb, 12:53 PM Raymed Labs - Quaterly Results 11 Feb, 12:53 PM Raymed Labs informs about resignation of CS cum CO 6 Jan, 2:47 PM Raymed Labs informs about compliance certificate 15 Jul, 5:18 PM Raymed Labs informs about certificate 13 Jan, 11:17 AM Raymed Labs informs about PCS certificate 26 Oct, 1:18 PM

Cresanto Global Stock Price Analysis and Quick Research Report. Is Cresanto Global an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Cresanto Global. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Cresanto Global has a PE ratio of -5.41623386259089 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Cresanto Global has ROA of -66.3401% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Cresanto Global has a Current ratio of 0.0399.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Cresanto Global has a ROE of 0%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Cresanto Global has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Cresanto Global has reported revenue growth of 0% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Cresanto Global for the current financial year is 0%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Cresanto Global is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Cresanto Global is Rs -0.6739. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Cresanto Global in Ticker for free. Also, one can get the intrinsic value of Cresanto Global by using Valuation Calculators, which are available with a Finology ONE subscription. 

Cresanto Global FAQs

Q1. What is Cresanto Global share price today?
Ans: The current share price of Cresanto Global is Rs 3.65.

Q2. What is the market capitalisation of Cresanto Global?
Ans: Cresanto Global has a market capitalisation of Rs 1.5598275 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Cresanto Global?
Ans: The PE ratio of Cresanto Global is -5.41623386259089 and the P/B ratio of Cresanto Global is -0.574830306943635, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Cresanto Global share?
Ans: The 52-week high share price of Cresanto Global is Rs 3.65, and the 52-week low share price of Cresanto Global is Rs 2.75.

Q5. Does Cresanto Global pay dividends?
Ans: Currently, Cresanto Global does not pay dividends. Dividend yield of Cresanto Global is around 0%.

Q6. What are the face value and book value of Cresanto Global shares?
Ans: The face value of Cresanto Global shares is Rs 10, while the book value per share of Cresanto Global is around Rs -6.3497. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Cresanto Global?
Ans: Cresanto Global has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Cresanto Global?
Ans: The ROE of Cresanto Global is 0% and ROCE of Cresanto Global is 0%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Cresanto Global a good buy for the long term?
Ans: The Cresanto Global long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Cresanto Global undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Cresanto Global appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Cresanto Global’s financials?
Ans: You can review Cresanto Global’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Cresanto Global
X